Vironova AB is a leading biotechnology company specializing in TEM-analysis of nanoparticles in biopharmaceutical development. With a strong focus on hardware, software, and services, we provide comprehensive solutions to the life science industry. Our mission is to make the invisible visible today, enabling clients to make better-informed decisions and ensuring safety for patients worldwide.

We offer a range of products and services, including genome length determination, AAV, adenoviral vectors, lentiviral vectors, liposomes and drug delivery, lipid nanoparticles, extracellular vesicles, inorganic materials, validation studies, GMP certified TEM QC service, and MiniTEM learning center. Our MiniTEM system is a compact and agile transmission electron microscope designed for automated nanoparticle characterization, providing reliable and accurate results. Additionally, our Vironova Analyzer Software (VAS) facilitates efficient TEM-based image analysis of nanoparticles, saving up to 12 hours of work per sample.

Backed by our world's only GMP-certified TEM laboratory, we deliver fast, traceable, and cost-effective electron microscopy services. With over 200 established customer relationships and a strong acquisition pipeline, Vironova is a trusted partner in the life science industry. Join us on our mission to build trust in the therapies of tomorrow